Correction: Mechanisms of mineralocorticoid receptor-associated hypertension in diabetes mellitus: the role of O-GlcNAc modification

Hypertens Res. 2023 Mar;46(3):814. doi: 10.1038/s41440-023-01167-4.

Rie Jo^{1

2}, Hirotaka Shibata^{3

4}, Isao Kurihara^{1

5}, Kenichi Yokota^{1

6}, Sakiko Kobayashi¹, Ayano Murai-Takeda^{1

7}, Yuko Mitsuishi^{1

8}, Takeshi Hayashi^{1

9}, Toshifumi Nakamura¹, Hiroshi Itoh¹

¹ Division of Endocrinology, Metabolism and Nephrology, Department of Internal Medicine, School of Medicine, Keio University, Tokyo, Japan.
² Keiyu Hospital, Kanagawa, Japan.
³ Division of Endocrinology, Metabolism and Nephrology, Department of Internal Medicine, School of Medicine, Keio University, Tokyo, Japan. [email protected].
⁴ Department of Endocrinology, Metabolism, Rheumatology and Nephrology, Faculty of Medicine, Oita University, Oita, Japan. [email protected].
⁵ Department of Medical Education, National Defense Medical College, Saitama, Japan.
⁶ Division of Metabolism and Endocrinology, Department of Internal Medicine, St. Marianna University School of Medicine, Kanagawa, Japan.
⁷ Health Center, Keio University, Kanagawa, Japan.
⁸ Center of Preventive Medicine, Keio University Hospital, Tokyo, Japan.
⁹ Hayashi Clinic, Tokyo, Japan.

No abstract available

Publication types